Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 60505-3659

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 60505-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sime_btl_lbl_50_1000mg (Sime Btl Lbl 50 1000mg)

Label for Sitagliptin and Metformin Hydrochloride Tablets, film-coated, with strengths of 50 mg sitagliptin and 1000 mg metformin. The label shows a 60-tablet count with NDC 60505-3659-6, manufactured by Apotex Corp. It includes storage instructions and a reference to the package insert for dosage information.*

FDA Label Image

Sime_btl_lbl_50_500mg (Sime Btl Lbl 50 500mg)

Label for Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg film-coated oral tablets. The label shows a quantity of 60 tablets, manufactured by Apotex Inc. with manufacturing and labeling locations in Toronto, Ontario, Canada and Weston, Florida. The label also includes storage instructions, dosage note to see package insert, and a pink tablet imprint '5-5'.*

FDA Label Image

Sitagliptinmetformin-01 (Sitagliptinmetformin 01)

Chemical structure of Sitagliptin and Metformin Hydrochloride, showing the molecular arrangement including the trifluoromethyl group, amino groups, and associated phosphate and water molecules as part of the compound.*

FDA Label Image

Sitagliptinmetformin-02 (Sitagliptinmetformin 02)

Chemical structure of metformin hydrochloride showing its molecular composition including methyl groups and a guanidine moiety.*

FDA Label Image

Sitagliptinmetformin-03 (Sitagliptinmetformin 03)

A line graph depicting least squares mean change from baseline over 24 weeks for various treatments including Placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, Sitagliptin 50 mg twice daily plus Metformin 500 mg twice daily, and Sitagliptin 50 mg twice daily plus Metformin 1000 mg twice daily. The x-axis shows weeks (0 to 24), and the y-axis represents the LS mean change from baseline.*

FDA Label Image

Sitagliptinmetformin-04 (Sitagliptinmetformin 04)

A line graph comparing the least squares (LS) mean change from baseline over 52 weeks between Sitagliptin 100 mg and Glipizide. The x-axis represents weeks, and the y-axis shows LS mean change from baseline. Both treatments show a similar trend of initial decrease followed by gradual increase.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.